I
Immuneering Corp
NASDAQ:IMRX
Immuneering Corp
NASDAQ:IMRX
Price:
4.96
USD
-1.78%
Market Closed
Market Cap:
$320.3m
Balance Sheet
Balance Sheet Decomposition
Immuneering Corp
Immuneering Corp
Balance Sheet Decomposition is not available for
Immuneering Corp
Immuneering Corp
Balance Sheet
Immuneering Corp
Immuneering Corp
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
14
|
37
|
75
|
73
|
59
|
36
|
|
| Cash Equivalents |
14
|
37
|
75
|
73
|
59
|
36
|
|
| Short-Term Investments |
0
|
0
|
74
|
33
|
26
|
0
|
|
| Total Receivables |
0
|
1
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
1
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
3
|
3
|
3
|
3
|
|
| Total Current Assets |
14
|
38
|
152
|
109
|
89
|
40
|
|
| PP&E Net |
0
|
1
|
6
|
6
|
5
|
5
|
|
| PP&E Gross |
0
|
1
|
6
|
6
|
5
|
5
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
1
|
1
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Goodwill |
0
|
0
|
7
|
7
|
7
|
7
|
|
| Long-Term Investments |
0
|
0
|
1
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
1
|
1
|
1
|
|
| Other Assets |
0
|
0
|
7
|
7
|
7
|
7
|
|
| Total Assets |
14
N/A
|
38
+172%
|
167
+334%
|
122
-27%
|
103
-16%
|
53
-49%
|
|
| Liabilities | |||||||
| Accounts Payable |
0
|
2
|
1
|
3
|
2
|
2
|
|
| Accrued Liabilities |
0
|
1
|
4
|
5
|
5
|
5
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
2
|
6
|
8
|
8
|
8
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
4
|
1
|
5
|
5
|
4
|
4
|
|
| Total Liabilities |
4
N/A
|
3
-30%
|
11
+282%
|
13
+17%
|
12
-4%
|
11
-6%
|
|
| Equity | |||||||
| Common Stock |
17
|
58
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
9
|
26
|
59
|
110
|
163
|
224
|
|
| Additional Paid In Capital |
2
|
3
|
215
|
220
|
254
|
266
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
10
N/A
|
36
+252%
|
156
+338%
|
110
-30%
|
91
-18%
|
41
-54%
|
|
| Total Liabilities & Equity |
14
N/A
|
38
+172%
|
167
+334%
|
122
-27%
|
103
-16%
|
53
-49%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
24
|
24
|
26
|
26
|
29
|
31
|
|
Switch to:
Switch to:
See Also
Discover More
